Compound details
Dihydrofolic acid
| Compound ID | CDAMM01776 |
|---|---|
| Common name | Dihydrofolic acid | IUPAC name | 2-[[4-[(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
| Molecular formula | C19H21N7O6 |
| Retention time | 5.09 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 444.167 | Theoretical mz | 444.162 |
| Error | 10.19 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.9966 |
| Inchi key | OZRNSSUDZOLUSN-LBPRGKRZSA-N |
|---|---|
| Smiles | O=C(O)CCC(NC(=O)C1=CC=C(C=C1)NCC2=NC=3C(=O)NC(=NC3NC2)N)C(=O)O |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P00491 | PNP | Purine nucleoside phosphorylase | T78198 | SEA |
| O43174 | CYP26A1 | Cytochrome P450 26A1 | T84634 | SEA |
| Q9H244 | P2RY12 | Purinergic receptor P2Y12 (by homology) | T46937 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| P00374 | DHFR | Dihydrofolate reductase | T17345 | SwissTargetPrediction and SEA |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SEA |
| P22102 | GART | GAR transformylase | T72042 | SwissTargetPrediction and SEA |
| Q99707 | MTR | Methionine synthase | T21661 | SEA |
| P15328 | FOLR1 | Folate receptor alpha | T83386 | SEA |
| P14207 | FOLR2 | Folate receptor beta | T82297 | SEA |
| Q96NT5 | SLC46A1 | Proton-coupled folate transporter | T19229 | SEA |
| P01275 | GCG | Glucagon | T44919 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T78198 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P00491 | PNP |
| T78198 | DI0167 | Gout | [ICD-11: FA25] | P00491 | PNP |
| T78198 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00491 | PNP |
| T78198 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P00491 | PNP |
| T78198 | DI0351 | Psoriasis | [ICD-11: EA90] | P00491 | PNP |
| T84634 | DI0314 | Oesophagitis | [ICD-11: DA24] | O43174 | CYP26A1 |
| T46937 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q9H244 | P2RY12 |
| T46937 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q9H244 | P2RY12 |
| T17345 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P00374 | DHFR |
| T17345 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00374 | DHFR |
| T17345 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P00374 | DHFR |
| T17345 | DI0427 | Urinary tract infection | [ICD-11: GC08] | P00374 | DHFR |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T72042 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P22102 | GART |
| T83386 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P15328 | FOLR1 |
| T83386 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P15328 | FOLR1 |
| T19229 | DI0150 | Folate deficiency anaemia | [ICD-11: 3A02] | Q96NT5 | SLC46A1 |
| T19229 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | Q96NT5 | SLC46A1 |
| T19229 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q96NT5 | SLC46A1 |
| T44919 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P01275 | GCG |
| T44919 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P01275 | GCG |
| T44919 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P01275 | GCG |
| T44919 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P01275 | GCG |
| T44919 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P01275 | GCG |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |